Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden
Dr David Erlinge is Professor of Cardiology at Lund University, Sweden Prof Erlinge is an interventional cardiologist focusing on PCI with a clinical interest in acute coronary syndromes. He is chairman of the Swedish PCI register (SCAAR) member of the board of SWEDEHEART.
He has been involved in the developing and leading registry based randomized clinical trials (RRCT) from TASTE, IFR-SWEDEHEART, DETO2X and was the leader of the pharmaceutical RRCT VALIDATE-SWEDEHEART, DAPA-MI and the diagnostic vulnerable plaque trial PROSPECT II.
Disclosure(s): chiesi, bracco: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); kaminari, medical: Consulting Fees (e.g., advisory boards) (Ongoing)
CRT 2026 Faculty Agreement to Participate
Saturday, March 7, 2026
8:00 AM - 8:00 PM EST